Severe low testosterone symptoms may necessitate starting with TRT, while significant weight loss goals might prioritize a GLP-1 like semaglutide. One of the biggest concerns when starting two medications at the same time is that if a side effect occurs, it can be difficult to know which one caused it, says Staheli
Clinical Equivalents: Ozempic, Wegovy
No: CL-SGTD-41 CAS No: NA Mol
Researchers value Sema for its: High stability under standard storage and handling conditions Excellent solubility in common research-grade diluents Consistency across experiments due to its chemical design and long half-life Studies have shown that Sema demonstrates strong GLP-1 receptor agonism, supporting its relevance in research focused on glucose homeostasis, appetite regulation, and weight management pathways
However, these treatments arent for long-term use
Once-weekly semaglutide in adults with overweight or obesity Summary: The STEP 1 trial showed a mean weight loss of 14.9% with once-weekly subcutaneous semaglutide 2.4 mg in individuals with overweight or obesity without type 2 diabetes
